<DOC>
	<DOC>NCT00683345</DOC>
	<brief_summary>Fatigue is a prevalent phenomenon in Primary Sjøgrens syndrome (PSS). Observations indicate that the cytokine IL-1 is of importance for this phenomenon. In this study the investigators block IL-1 by giving Anakinra (an IL-1 receptor antagonist) to patients with PSS.</brief_summary>
	<brief_title>Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome</brief_title>
	<detailed_description>A double-blind, placebo-controlled, parallel study of the effect on fatigue of daily injections of Anakinra for one month.</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sjogren's Syndrome</mesh_term>
	<mesh_term>Interleukin 1 Receptor Antagonist Protein</mesh_term>
	<criteria>Primary Sjøgrens Syndrome according to the EuropeanAmerican criteria Age 1880 years Written informed consent Hyper og hypothyreosis Malignant disease Parkinsons disease Multiple sclerosis Conditions or diseases where Anakinra is contraindicated Mental depression (BDI &gt;13) Neutropenia (&lt;1.5*10.9) Frequent infections Pregnancy, lactating women.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>